Endothelial Matrin‐3 Limits Cellular Senescence and Lipid Dysregulation to Protect Against Murine Atherosclerosis
The FASEB Journal · 31.10.2026 · 40 (20)
DOI: 10.1096/fj.202602809rr ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, online erschienen am 17.10.2026. Verfasst von Xiao Cheng und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, University of Nebraska-Lincoln, Lincoln, Nebraska, USA. Hauptthemen laut MEDLINE: Atherosclerosis, Cellular Senescence, RNA-Binding Proteins, Lipid Metabolism. Die Arbeit nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI), NIDDK NIH HHS.
Abstract (Originalsprache)
Matrin‐3 is a DNA‐ and RNA‐binding protein implicated in cardiovascular development. However, the role of endothelial Matrin‐3 in atherosclerosis has not been previously studied. Here, we found that Matrin‐3 silencing induces endothelial senescence, characterized by reduced cell proliferation, increased senescence‐associated β‐galactosidase activity, and impaired mitochondrial function in vitro. Quantitative proteomics and bulk RNA‐sequencing identified hundreds of differentially expressed genes and proteins in human endothelial cells. Bioinformatic analyses revealed enrichment of pathways related to DNA replication, p53 signaling, cell‐cycle regulation, and cellular senescence. To examine the role of endothelial Matrin‐3 in atherosclerosis, we generated Matrin‐3 floxed mice on a low‐density lipoprotein receptor‐knockout background and crossed them with mice carrying an endothelial cell‐specific, tamoxifen‐inducible Cre driver. In a mouse model of atherosclerosis, endothelial cell‐specific Matrin‐3 deficiency increased atherosclerotic lesion area by 1.41‐fold and was associated with increased plasma low‐density lipoprotein cholesterol and triglycerides, increased hepatic cholesterol and triglycerides, and substantial transcriptional alterations in the aortic intima. Endothelial Matrin‐3 deficiency also induced hepatic steatosis, fibrosis, inflammation, and endothelial senescence. Single‐nucleus RNA‐sequencing of the liver further revealed transcriptional reprogramming of hepatocytes, including alterations in pathways related to lipid metabolism, inflammation, and constitutive androstane receptor signaling, consistent with a functional link between endothelial Matrin‐3 deficiency and hepatocyte transcriptional responses. Finally, Matrin‐3 expression was reduced in mouse and human atherosclerotic plaques. Together, these findings identify endothelial Matrin‐3 as an important regulator of endothelial senescence and lipid homeostasis and demonstrate that endothelial Matrin‐3 deficiency is associated with both local vascular alterations and systemic metabolic dysfunction in atherosclerosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry, University of Nebraska-Lincoln, Lincoln, Nebraska, USA.
- Nebraska Center for the Prevention of Obesity Diseases Through Dietary Molecules, University of Nebraska-Lincoln, Lincoln, Nebraska, USA.
ORCID-Profile: Xinghui Sun
Förderung
- NHLBI NIH HHS
- HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI)
- NIDDK NIH HHS
- NIGMS NIH HHS
- HHS | NIH | National Institute of General Medical Sciences (NIGMS)
- HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- National Institute of Diabetes and Digestive and Kidney Diseases
- National Institute of General Medical Sciences
Zitieren
APA
Cheng, X., Tanni, F. Y., Zoni, R. N., Abdollahi, E., Childs, E., & Sun, X. (2026). Endothelial Matrin‐3 Limits Cellular Senescence and Lipid Dysregulation to Protect Against Murine Atherosclerosis. The FASEB Journal, 40(20). https://doi.org/10.1096/fj.202602809rr
Vancouver
Cheng X, Tanni FY, Zoni RN, Abdollahi E, Childs E, Sun X. Endothelial Matrin‐3 Limits Cellular Senescence and Lipid Dysregulation to Protect Against Murine Atherosclerosis. The FASEB Journal. 2026;40(20). doi:10.1096/fj.202602809rr
BibTeX
@article{Cheng2026,
author = {Cheng, Xiao and Tanni, Fatema Yeasmin and Zoni, Rachelle Nelson and Abdollahi, Elham and Childs, Eli and Sun, Xinghui},
title = {Endothelial Matrin‐3 Limits Cellular Senescence and Lipid Dysregulation to Protect Against Murine Atherosclerosis},
journal = {The FASEB Journal},
year = {2026},
volume = {40},
number = {20},
doi = {10.1096/fj.202602809rr}
}
EUVIMED